This is a discussion on TA82: Atopic dermatitis (eczema) - pimecrolimus and tacrolimus within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Atopic dermatitis (eczema) - pimecrolimus and tacrolimus. It links to the published guidance ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
The summary for the published technology appraisal on Atopic dermatitis (eczema) - pimecrolimus and tacrolimus. It links to the published guidance and key documents.
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA81: Atopic dermatitis (eczema) - topical steroids | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA177: Eczema (chronic) - alitretinoin | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA177: Eczema (chronic) - alitretinoin | industry_news | Updates from the Technology Assessment Authorities | 0 | 08-26-2009 12:26 AM |
| US Children, Adults Referred for Patch Test Equally Likely to Have Contact Dermatitis | industry_news | Other Clinical Pharmacy News | 0 | 10-20-2008 06:23 PM |
| Astellas Wins Japan Approval for Once-Daily Formulation of Tacrolimus | industry_news | Other Clinical Pharmacy News | 0 | 07-18-2008 07:44 AM |